Maxamine H2 receptor agonist: Update

Patients will receive one of two regimens. One will be a high dose of interleukin-2 (IL-2) alone twice a day on days 1

Read the full 238 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE